15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering InnovAge Holding Corp, 1 rate it Buy or better, 0 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets span $7.00 to $13.00, a moderate spread. The average target of $10.00 sits 5% below the current $10.52. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 0 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.10 next quarter toward $0.41 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Hold
Strong Buy00%
Buy150%
Hold00%
Sell150%
Strong Sell00%
Based on 2 analysts giving stock ratings to InnovAge Holding Corp.
As of Sep, 1 of 2 firms rate INNV a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
INNV EPS & revenue forecast
EPS · NEXT QUARTER
$0.10
Range $0.10 – $0.10 · 1 analysts · +43% YoY
Next period, 1 analysts expect InnovAge Holding Corp to earn $0.10 a share (range $0.10 – $0.10), versus $0.07 a year earlier. Full-year consensus is $0.36, growing to $0.41 the year after.
REVENUE · NEXT QUARTER
$252.5M
Range $248.0M – $257.0M · 1 analysts · +7% YoY
Revenue is expected to reach $252.5M (range $248.0M – $257.0M), +6.9% year-over-year., rising to $1.0B next year.
Top analysts covering InnovAge Holding Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INNV.
#1
BR
Benjamin Rossi
JP Morgan
Sell
$7.00-33.5% to target
Coverage
—
+ Follow
#2
MG
Matthew Gillmor
Keybanc
Buy
$13.00+23.6% to target
Coverage
—
+ Follow
#3
JH
Jared Haase
William Blair
Hold
No targeton INNV
Coverage
—
+ Follow
#4
MG
Matthew Gillmor CFA
KeyBanc
Hold
No targeton INNV
Coverage
—
+ Follow
#5
Lisa Gill
JP Morgan
Sell
$5.00-52.5% to target
Coverage
—
+ Follow
INNV stock forecast FAQ
What is INNV's average 12-month price target?+
The 2 analysts with a live target average $10.00 for InnovAge Holding Corp over the next 12 months, ranging from a $13.00 high to a $7.00 low.
Is INNV stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 2 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for INNV?+
The Street-high target is $13.00 (Keybanc), and the Street-low is $7.00 (JP Morgan). The average of all 2 active targets is $10.00.
How many Wall Street analysts cover INNV?+
2 analysts have an active rating on InnovAge Holding Corp, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering INNV?+
Among analysts who currently cover INNV, Benjamin Rossi of JP Morgan has the strongest overall Quantellect track record. Their current call is Sell with a $7.00 target.
What is InnovAge Holding Corp's projected EPS for next quarter?+
The consensus estimate is $0.10 per share (range $0.10 – $0.10) across 1 analysts. Full-year EPS is projected at $0.36, rising to $0.41 the following year.
How much revenue is InnovAge Holding Corp expected to report next quarter?+
Consensus revenue is $252.5M (range $248.0M – $257.0M). Full-year revenue is projected at —, growing to $1.0B next year.
Have analysts been upgrading or downgrading INNV lately?+
As of Sep, 1 of 2 firms rate INNV a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INNV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
